Drug
News
Questions?
(888) 391-1315
Prescription Drugs
Medical Devices
Legal Options
News
Prescription Drugs
Actemra
Actos
Belviq
Concerta
Depo-Provera
Elmiron
Invokana
Oxbryta
Ozempic
Risperdal
Suboxone
Uloric
Viberzi
Xarelto
Xeljanz
Zantac
Medical Devices
Bard PowerPort Catheter
CPAP Recall
Depuy Hip
Depuy Synthes Knee
Epipen Failure
Exactech Hip & Knee
Hernia Mesh
Hip Implants (Metal)
IVC Filters
Paragard IUD
Stryker Hip
Talcum Powder
Transvaginal Mesh
Zimmer Shoulder Implant
Legal options
3M Defective Earplugs
Asbestos Lung Cancer
Birth Injuries
Cerebral Palsy
Camp Lejeune Contamination
Diabetes Drugs
Essure Complications
Formula NEC
Heater-Cooler Infection
Incretin Drugs
Metal Hip Revisions
Monsanto Roundup & Cancer
Sunscreen Benzene
Tuesday, October 25, 2016
Stryker Hip
New Warning Issued for Stryker Hip Implants
Read
Thursday, October 20, 2016
Xarelto
Anticoagulant
FDA & British Medical Journal Disagree on Safety of Xarelto
Read
Wednesday, October 19, 2016
IVC Filter
New Reports Question Safety of IVC Blood Clot Filters As Lawsuits Mount
Read
Friday, September 30, 2016
FDA Recalls
DrugNews' Weekly FDA Recall & Warning Report for September 29, 2016
Read
Monday, September 26, 2016
Invokana
Diabetes
Victims Ask to Consolidate Invokana Kidney Lawsuits as New Data Raises Questions
Read
Thursday, September 15, 2016
Xarelto
Eliquis
Anticoagulant
Will Xarelto, Eliquis Antidote Come in Time to Save Thousands?
Read
Wednesday, August 24, 2016
FDA Recalls
DrugNews' Mid-August FDA Recall & Warning Recap
Read
Tuesday, August 16, 2016
Xarelto
Pradaxa
Eliquis
Anticoagulant
New Studies Announced to Compare All Blood Thinner Drugs for First Time
Read
Thursday, August 4, 2016
FDA Recalls
DrugNews' Weekly FDA Recalls & Warnings Recap - August 1, 2016
Read
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Get in touch with us.
Call, email or live chat with us today to see how we can help.
Need a quick answer? Call us!
(888) 391-1315
Reach out to us by email.
info@drugnews.net
We are here to help now
Start live chat
